Pharma Journalist 9027 posts 0 comments

Artiva Biotherapeutics, Inc. (“Artiva”), an oncology company focused on developing and commercializing primary allogeneic natural killer (NK) cell therapies to treat cancer, announced…
Read More...

ProBioGen is pleased to announce that Nobelpharma has signed a license agreement for the use of the AGE1.CR.pIX vaccine production platform to develop their lead vaccine. The signing of…
Read More...

Sheba Medical Center at Tel Hashomer, the largest hospital in the Middle East region, and Lonza, a leading global cell and gene therapy manufacturer, announced today that they have…
Read More...

Precision NanoSystems (PNI), a global leader in innovative solutions for genetic medicine development, will expand its global headquarters with a 75,000-square-foot facility currently…
Read More...

Have you secured your FREE pass to the 𝐆𝐚𝐬𝐭𝐫𝐨𝐢𝐧𝐭𝐞𝐬𝐭𝐢𝐧𝐚𝐥 𝐂𝐚𝐧𝐜𝐞𝐫 𝐃𝐫𝐮𝐠 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐒𝐮𝐦𝐦𝐢𝐭 yet? It’s free-to-attend for drug developers, research, institutions and not-for-profit…
Read More...

There’s only 2 weeks to go until the 𝐍𝐞𝐮𝐫𝐨𝐩𝐚𝐭𝐡𝐢𝐜 𝐏𝐚𝐢𝐧 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 𝐒𝐮𝐦𝐦𝐢𝐭 takes place online this August 24-25. Have you booked your ticket? Here are some top reasons to attend: 𝟐𝟒+ …
Read More...

GentiBio, Inc., a biotherapeutics company developing engineered regulatory T cells (Tregs) therapies for immunology,  announced it has closed on a Series A financing generating…
Read More...

C4 Therapeutics, Inc. (C4T) a clinical-stage biopharmaceutical company pioneering a new class of small-molecule medicines that selectively destroy disease-causing proteins through…
Read More...

Vensica Therapeutics ("Vensica"), a clinical stage biopharmaceutical company, announced that it has signed a strategic collaboration agreement with Merz Therapeutics, a business of the…
Read More...

Evotec SE announced the opening of the company’s late-stage clinical and commercial biologics cGMP manufacturing facility (J.POD 1 US) in Redmond, Washington. The innovative cGMP…
Read More...